CSL – the star performer in manufacturing

Analysis by Peter Roberts Blood and vaccine product company CSL (ASX: CSL) is living proof that manufacturing can not only prosper from an Australian base, but can find support among Australian investors. The company along with medical device makers, Cochlear and ResMed, stands alone in an investment landscape that otherwise is patchy in its support…

Talga Resources makes progress in graphene

Australian minerals technology company, Talga Resources (ASX: TLG) is progressing development of its graphene resources with potential end users in Europe and the Asia. The company announced that its December quarter saw intensified R&D activities, deepening alliances and new commercial agreements. Talga managing director, Mark Thompson said test results of several graphene battery products during…

De.mem reports increased sales

Singapore-Australian water and wastewater treatment company, De.mem (ASX: DEM), achieved sales growth of 262 per cent in 2019, according to a company announcment. The company, which produces membrane filtration systems in Singapore and Queensland, recorded revenues of $10.5 million in the year, up from $2.9 million in 2017. De.mem chief executive, Andreas Kroell said: “(Calendar…